Related Experiment Videos
Recent developments in understanding the pathogenesis of aplastic anemia.
American Journal of Hematology
|January 1, 1978
Summary
Aplastic anemia (AA) often stems from damage to hematopoietic stem cells. Research suggests AA may encompass multiple distinct diseases sharing similar features, rather than a single cause.
Area of Science:
- Hematology
- Stem Cell Biology
- Immunology
Background:
- Aplastic anemia (AA) is characterized by bone marrow failure.
- Potential causes include hematopoietic stem cell abnormalities, dysregulated hematopoiesis, or an altered hematopoietic environment.
Purpose of the Study:
- To review current understanding of the pathogenetic mechanisms underlying aplastic anemia.
- To explore the roles of stem cell injury, immune suppression, and the microenvironment in AA pathogenesis.
Main Methods:
- Review of studies in human patients and animal models.
- Analysis of bone marrow transplantation data.
- In vitro studies of hematopoietic stem cells and immune interactions.
Main Results:
- Evidence strongly suggests that injuries to hematopoietic stem cells are the most frequent cause of AA in humans and murine models.
- While immune suppression of hematopoiesis is implicated in some human AA cases, defective humoral or cellular control has not been identified.
- Abnormalities of the hematopoietic microenvironment are suggested but lack direct supporting studies.
Conclusions:
- Aplastic anemia likely represents a heterogeneous group of diseases with shared clinical and morphological characteristics.
- Hematopoietic stem cell injury is a primary mechanism, with immune-mediated damage playing a role in some instances.